Home Unlearn.AI

Unlearn.AI

In operation
Series C
AI Drug Trial Instrument Developer
Basic
Enterprise Profile

Basic Information

Unlearn is the only company that uses artificial intelligence to create Digital Twins for intelligent control arms in clinical research. By leveraging historical datasets and machine learning models specific to diseases, Unlearn generates virtual placebo patients from actual patient baseline data in clinical studies. This novel approach enhances the power and confidence of trials, accelerates trial timelines, and enables patient-level insights. Founded in 2017 by a team of world-class machine learning scientists who share a common vision of streamlining clinical trials through machine learning, Unlearn continues to engage in discussions with regulators, industry leaders, and other key stakeholders. The company is also seeking partners to help drive innovation in clinical research using artificial intelligence.
Unlearn.AI, Inc.
SanFrancisco,California,United States of America
15~50 people
January 01, 2017
info@unlearn.ai

Enterprise Profile

Industrial Sector
Drug Trial Medical Device R&D and Design CRO
Technology
Machine Learning
Concept
Disease Treatment
Application Scenarios
AI+Pharmaceuticals